Glycemic Control
T2DM, diabetes
REMISSION, DIABETES
All participants showed robust glycemic improvement and antidiabetic medications were discontinued, without need for recommencing at 6 months. Among 24 patients, 23 (95%) had complete remission of T2DM, while one patient from the LRYGBP+FR group experienced relapse of diabetes and reintroduction to oral medications at 12 months. HbA1c, C-peptide, and HOMA-IR demonstrated significant amelioration in both groups (Fasting insulin values showed comparable decrease in both groups at 6 and 12 months (The insulinogenic index was increased statistically significant in both groups (